Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;9(1):13-24.
doi: 10.1038/nrneurol.2012.242. Epub 2012 Nov 27.

100 years of Lewy pathology

Michel Goedert  1 , Maria Grazia Spillantini, Kelly Del Tredici, Heiko Braak
Affiliations

100 years of Lewy pathology

Michel Goedert et al. Nat Rev Neurol. 2013 Jan.

Abstract

In 1817, James Parkinson described the symptoms of the shaking palsy, a disease that was subsequently defined in greater detail, and named after Parkinson, by Jean-Martin Charcot. Parkinson expected that the publication of his monograph would lead to a rapid elucidation of the anatomical substrate of the shaking palsy; in the event, this process took almost a century. In 1912, Fritz Heinrich Lewy identified the protein aggregates that define Parkinson disease (PD) in some brain regions outside the substantia nigra. In 1919, Konstantin Nikolaevich Tretiakoff found similar aggregates in the substantia nigra and named them after Lewy. In the 1990s, α-synuclein was identified as the main constituent of the Lewy pathology, and its aggregation was shown to be central to PD, dementia with Lewy bodies, and multiple system atrophy. In 2003, a staging scheme for idiopathic PD was introduced, according to which α-synuclein pathology originates in the dorsal motor nucleus of the vagal nerve and progresses from there to other brain regions, including the substantia nigra. In this article, we review the relevance of Lewy's discovery 100 years ago for the current understanding of PD and related disorders.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Mol Neurosci. 2001 Oct;17(2):225-32 - PubMed
    1. PLoS One. 2011 Apr 29;6(4):e19338 - PubMed
    1. Acta Neuropathol. 2007 Apr;113(4):421-9 - PubMed
    1. Science. 1997 Jun 27;276(5321):2045-7 - PubMed
    1. Nat Cell Biol. 2002 Feb;4(2):160-4 - PubMed

Substances

Personal name as subject